Tag results:
CD8
Human Immunology News
Depletion of Central Memory CD8+ T Cells Might Impede the Antitumor Therapeutic Effect of Mogamulizumab
[Nature Communications] The authors showed that despite a significant reduction in peripheral effector Treg cells, clinical responses are minimal in a cohort of patients with advanced CCR4-negative solid cancer in a Phase Ib study.
Dermal Cell News
SOX10 Requirement for Melanoma Tumor Growth Is Due, in Part, to Immune-Mediated Effects
[Cell Reports] Researchers investigated immune-related targets of SOX10 and observed positive regulation of herpesvirus entry mediator and carcinoembryonic-antigen cell-adhesion molecule 1.
Hematopoiesis News
Impact of Hydroxyurea on Lymphocyte Subsets in Children with Sickle Cell Anemia
[Pediatric Research] Scientists evaluated the effect of hydroxyurea on immune profiles through a controlled prospective cohort study conducted in 30 children with sickle cell anemia and 30 healthy age-matched controls.
Immunology of Infectious Disease News
Longitudinal Analysis of Memory T Cell Responses in Survivors of Middle East Respiratory Syndrome
[Clinical infectious Diseases] The authors investigated cellular immune responses up to five years after infection in a cohort of 59 Middle East respiratory syndrome survivors by performing ELISPOT assay and intracellular cytokine staining after stimulation of peripheral blood mononuclear cells with synthetic viral peptides.
Immune Regulation News
Genome-Wide Fitness Gene Identification Reveals Roquin as a Potent Suppressor of CD8 T Cell Expansion and Anti-Tumor Immunity
[Cell Reports] Investigators performed in vivo and in vitro CRISPR screens to systematically identify genes influencing CD8 T cell expansion.
Immunology of Infectious Disease News
Foxp3+ CD4+ Regulatory T Cells Control Dendritic Cells in Inducing Antigen-Specific Immunity to Emerging SARS-CoV-2 Antigens
[PLoS Pathogens] Investigators examined the effect of transient breakdown of the immunological tolerance induced by Treg-cell depletion on adaptive immune responses against administered SARS-CoV-2 antigen, spike protein 1.